YIELD10 BIOSCIENCE INC (YTEN) Fundamental Analysis & Valuation

NASDAQ:YTEN • US98585K8541

Current stock price

2.88 USD
-2.38 (-45.25%)
At close:
2.89 USD
+0.01 (+0.35%)
After Hours:

This YTEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. YTEN Profitability Analysis

1.1 Basic Checks

  • In the past year YTEN has reported negative net income.
  • In the past year YTEN has reported a negative cash flow from operations.
  • YTEN had negative earnings in each of the past 5 years.
  • In the past 5 years YTEN always reported negative operating cash flow.
YTEN Yearly Net Income VS EBIT VS OCF VS FCFYTEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of YTEN (-370.00%) is worse than 96.74% of its industry peers.
Industry RankSector Rank
ROA -370%
ROE N/A
ROIC N/A
ROA(3y)-197.19%
ROA(5y)-147.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YTEN Yearly ROA, ROE, ROICYTEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for YTEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YTEN Yearly Profit, Operating, Gross MarginsYTEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. YTEN Health Analysis

2.1 Basic Checks

  • YTEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • YTEN has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for YTEN is higher compared to a year ago.
YTEN Yearly Shares OutstandingYTEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
YTEN Yearly Total Debt VS Total AssetsYTEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • YTEN has an Altman-Z score of -157.47. This is a bad value and indicates that YTEN is not financially healthy and even has some risk of bankruptcy.
  • YTEN has a worse Altman-Z score (-157.47) than 98.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -157.47
ROIC/WACCN/A
WACC9.13%
YTEN Yearly LT Debt VS Equity VS FCFYTEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

  • YTEN has a Current Ratio of 0.29. This is a bad value and indicates that YTEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • YTEN has a Current ratio of 0.29. This is amonst the worse of the industry: YTEN underperforms 96.57% of its industry peers.
  • YTEN has a Quick Ratio of 0.29. This is a bad value and indicates that YTEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of YTEN (0.29) is worse than 96.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
YTEN Yearly Current Assets VS Current LiabilitesYTEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. YTEN Growth Analysis

3.1 Past

  • The earnings per share for YTEN have decreased strongly by -1075.36% in the last year.
  • The Revenue for YTEN has decreased by -86.67% in the past year. This is quite bad
  • The Revenue for YTEN have been decreasing by -36.03% on average. This is quite bad
EPS 1Y (TTM)-1075.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-867.16%
Revenue 1Y (TTM)-86.67%
Revenue growth 3Y-57.83%
Revenue growth 5Y-36.03%
Sales Q2Q%-100%

3.2 Future

  • Based on estimates for the next years, YTEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.95% on average per year.
  • YTEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 288.42% yearly.
EPS Next Y97.63%
EPS Next 2Y40.47%
EPS Next 3Y25.9%
EPS Next 5Y14.95%
Revenue Next Year2712.5%
Revenue Next 2Y607.11%
Revenue Next 3Y594.08%
Revenue Next 5Y288.42%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YTEN Yearly Revenue VS EstimatesYTEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
YTEN Yearly EPS VS EstimatesYTEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. YTEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for YTEN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for YTEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YTEN Price Earnings VS Forward Price EarningsYTEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YTEN Per share dataYTEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as YTEN's earnings are expected to grow with 25.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.47%
EPS Next 3Y25.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. YTEN Dividend Analysis

5.1 Amount

  • No dividends for YTEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

YTEN Fundamentals: All Metrics, Ratios and Statistics

YIELD10 BIOSCIENCE INC

NASDAQ:YTEN (5/15/2024, 8:18:42 PM)

After market: 2.89 +0.01 (+0.35%)

2.88

-2.38 (-45.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-08
Earnings (Next)08-12
Inst Owners1.81%
Inst Owner Change0%
Ins Owners1.67%
Ins Owner Change0%
Market Cap44.35M
Revenue(TTM)60.00K
Net Income(TTM)-14.46M
Analysts45.71
Price Target12.24 (325%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.51%
Min EPS beat(2)-2.19%
Max EPS beat(2)13.21%
EPS beat(4)1
Avg EPS beat(4)-5.53%
Min EPS beat(4)-17.65%
Max EPS beat(4)13.21%
EPS beat(8)2
Avg EPS beat(8)-4.93%
EPS beat(12)4
Avg EPS beat(12)-2.47%
EPS beat(16)6
Avg EPS beat(16)-1.17%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2300%
PT rev (3m)433.33%
EPS NQ rev (1m)-2300%
EPS NQ rev (3m)-738.09%
EPS NY rev (1m)0%
EPS NY rev (3m)19.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)101.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 739.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-32.44
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS0
BVpS-0.16
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -370%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-197.19%
ROA(5y)-147.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.86%
Cap/Sales 76.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -157.47
F-Score2
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)53.31%
Cap/Depr(5y)46.87%
Cap/Sales(3y)47.05%
Cap/Sales(5y)31.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1075.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-867.16%
EPS Next Y97.63%
EPS Next 2Y40.47%
EPS Next 3Y25.9%
EPS Next 5Y14.95%
Revenue 1Y (TTM)-86.67%
Revenue growth 3Y-57.83%
Revenue growth 5Y-36.03%
Sales Q2Q%-100%
Revenue Next Year2712.5%
Revenue Next 2Y607.11%
Revenue Next 3Y594.08%
Revenue Next 5Y288.42%
EBIT growth 1Y-7.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.31%
EBIT Next 3Y16.98%
EBIT Next 5Y24.41%
FCF growth 1Y12.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.68%
OCF growth 3YN/A
OCF growth 5YN/A

YIELD10 BIOSCIENCE INC / YTEN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for YIELD10 BIOSCIENCE INC?

ChartMill assigns a fundamental rating of 1 / 10 to YTEN.


Can you provide the valuation status for YIELD10 BIOSCIENCE INC?

ChartMill assigns a valuation rating of 1 / 10 to YIELD10 BIOSCIENCE INC (YTEN). This can be considered as Overvalued.


How profitable is YIELD10 BIOSCIENCE INC (YTEN) stock?

YIELD10 BIOSCIENCE INC (YTEN) has a profitability rating of 0 / 10.


What is the expected EPS growth for YIELD10 BIOSCIENCE INC (YTEN) stock?

The Earnings per Share (EPS) of YIELD10 BIOSCIENCE INC (YTEN) is expected to grow by 97.63% in the next year.